Effects of indomethacin on furosemide-stimulated urinary PgE2 excretion in man

D. C. Brater, J. M. Beck, B. V. Adams, W. B. Campbell

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We studied the effects of furosemide on urinary excretion of PGE2 and sodium and the effects of inhibition of prostaglandin (PG) synthesis with indomethacin or furosemide-induced PGE2 excretion and natriuresis in normal man. Furosemide (20 mg i.v.) increased the urinary excretion of PGE2 from 71.2 ± 17.2 to 255.9 ± 41.0ng/4h. Sodium excretion increased in parallel. Indomethacin, in a dose sufficient to decrease basal urinary PGE2 excretion by >90%, significantly decreased both urinary PGE2 and sodium excretion under furosemide without affecting delivery of furosemide into the urine. The urinary excretion of furosemide was 9.4 ± 0.4 and 9.3 ± 1.4 mg/24 h with and without indomethacin, respectively. However, the furosemide-induced increment in PGE2 excretion and sodium excretion over baseline was not changed. Furosemide-stimulated urinary PGE2 excretion correlated significantly with sodium excretion rate with and without indomethacin. Indomethacin changed the relationship between absolute amounts of furosemide in urine and PGE2 excretion but did not affect the increment in excretion over baseline or the significant correlation of urinary PGE2 with sodium excretion.

Original languageEnglish (US)
Pages (from-to)213-219
Number of pages7
JournalEuropean Journal of Pharmacology
Volume65
Issue number2-3
StatePublished - 1980

Fingerprint

Furosemide
Dinoprostone
Indomethacin
Sodium
Urine
Natriuresis
Prostaglandins

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effects of indomethacin on furosemide-stimulated urinary PgE2 excretion in man. / Brater, D. C.; Beck, J. M.; Adams, B. V.; Campbell, W. B.

In: European Journal of Pharmacology, Vol. 65, No. 2-3, 1980, p. 213-219.

Research output: Contribution to journalArticle

Brater, D. C. ; Beck, J. M. ; Adams, B. V. ; Campbell, W. B. / Effects of indomethacin on furosemide-stimulated urinary PgE2 excretion in man. In: European Journal of Pharmacology. 1980 ; Vol. 65, No. 2-3. pp. 213-219.
@article{bd060791eeab4199b4206dccdcfb032b,
title = "Effects of indomethacin on furosemide-stimulated urinary PgE2 excretion in man",
abstract = "We studied the effects of furosemide on urinary excretion of PGE2 and sodium and the effects of inhibition of prostaglandin (PG) synthesis with indomethacin or furosemide-induced PGE2 excretion and natriuresis in normal man. Furosemide (20 mg i.v.) increased the urinary excretion of PGE2 from 71.2 ± 17.2 to 255.9 ± 41.0ng/4h. Sodium excretion increased in parallel. Indomethacin, in a dose sufficient to decrease basal urinary PGE2 excretion by >90{\%}, significantly decreased both urinary PGE2 and sodium excretion under furosemide without affecting delivery of furosemide into the urine. The urinary excretion of furosemide was 9.4 ± 0.4 and 9.3 ± 1.4 mg/24 h with and without indomethacin, respectively. However, the furosemide-induced increment in PGE2 excretion and sodium excretion over baseline was not changed. Furosemide-stimulated urinary PGE2 excretion correlated significantly with sodium excretion rate with and without indomethacin. Indomethacin changed the relationship between absolute amounts of furosemide in urine and PGE2 excretion but did not affect the increment in excretion over baseline or the significant correlation of urinary PGE2 with sodium excretion.",
author = "Brater, {D. C.} and Beck, {J. M.} and Adams, {B. V.} and Campbell, {W. B.}",
year = "1980",
language = "English (US)",
volume = "65",
pages = "213--219",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Effects of indomethacin on furosemide-stimulated urinary PgE2 excretion in man

AU - Brater, D. C.

AU - Beck, J. M.

AU - Adams, B. V.

AU - Campbell, W. B.

PY - 1980

Y1 - 1980

N2 - We studied the effects of furosemide on urinary excretion of PGE2 and sodium and the effects of inhibition of prostaglandin (PG) synthesis with indomethacin or furosemide-induced PGE2 excretion and natriuresis in normal man. Furosemide (20 mg i.v.) increased the urinary excretion of PGE2 from 71.2 ± 17.2 to 255.9 ± 41.0ng/4h. Sodium excretion increased in parallel. Indomethacin, in a dose sufficient to decrease basal urinary PGE2 excretion by >90%, significantly decreased both urinary PGE2 and sodium excretion under furosemide without affecting delivery of furosemide into the urine. The urinary excretion of furosemide was 9.4 ± 0.4 and 9.3 ± 1.4 mg/24 h with and without indomethacin, respectively. However, the furosemide-induced increment in PGE2 excretion and sodium excretion over baseline was not changed. Furosemide-stimulated urinary PGE2 excretion correlated significantly with sodium excretion rate with and without indomethacin. Indomethacin changed the relationship between absolute amounts of furosemide in urine and PGE2 excretion but did not affect the increment in excretion over baseline or the significant correlation of urinary PGE2 with sodium excretion.

AB - We studied the effects of furosemide on urinary excretion of PGE2 and sodium and the effects of inhibition of prostaglandin (PG) synthesis with indomethacin or furosemide-induced PGE2 excretion and natriuresis in normal man. Furosemide (20 mg i.v.) increased the urinary excretion of PGE2 from 71.2 ± 17.2 to 255.9 ± 41.0ng/4h. Sodium excretion increased in parallel. Indomethacin, in a dose sufficient to decrease basal urinary PGE2 excretion by >90%, significantly decreased both urinary PGE2 and sodium excretion under furosemide without affecting delivery of furosemide into the urine. The urinary excretion of furosemide was 9.4 ± 0.4 and 9.3 ± 1.4 mg/24 h with and without indomethacin, respectively. However, the furosemide-induced increment in PGE2 excretion and sodium excretion over baseline was not changed. Furosemide-stimulated urinary PGE2 excretion correlated significantly with sodium excretion rate with and without indomethacin. Indomethacin changed the relationship between absolute amounts of furosemide in urine and PGE2 excretion but did not affect the increment in excretion over baseline or the significant correlation of urinary PGE2 with sodium excretion.

UR - http://www.scopus.com/inward/record.url?scp=0018883950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018883950&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 213

EP - 219

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -